Eiken Chemical
4549.TTSE PRIMEPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Dalton Investments, Inc. | 17.92% |
| NIPPON ACTIVE VALUE FUND PLC | 9.46% |
| Asset Value Investors Limited | 7.37% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 7
| NAVF Select (Master) Fund LP | 3.62% |
| NAVF Select LLC | 3.57% |
| T. Rowe Price Japan, Inc. | 3.36% |
| - | 2.94% |
| Amova Asset Management Co., Ltd. | 2.28% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd. | 2.14% |
| - | 0.77% |
Ownership history · 90
| Holder | Ratio | Change |
|---|---|---|
| NAVF Select LLC2024-03-26 | 1.22% | +0.08pp |
| Dalton Investments, Inc.2024-03-26 | 2.17% | +0.77pp |
| NIPPON ACTIVE VALUE FUND PLC2024-03-26 | 4.84% | +0.34pp |
| Asset Value Investors Limited2024-03-11 · amended | 6.01% | new |
| NAVF Select LLC2024-02-08 | 1.14% | no change |
| Dalton Investments, Inc.2024-02-08 | 1.40% | no change |
| NIPPON ACTIVE VALUE FUND PLC2024-02-08 | 4.50% | no change |
| NAVF Select LLC2024-02-06 | 1.14% | new |
| Dalton Investments, Inc.2024-02-06 | 1.40% | new |
| NIPPON ACTIVE VALUE FUND PLC2024-02-06 | 4.50% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.